{"id":"W2803149877","doi":"10.6004/jnccn.2018.0046","title":"Targeted Therapy for Patients With Metastatic Non–Small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Journal of the National Comprehensive Cancer Network","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Seagen (Canada)","funders":"Ariad Pharmaceuticals","keywords":"Medicine; Alectinib; Osimertinib; ROS1; Targeted therapy; Lung cancer; Oncology; Anaplastic lymphoma kinase; Erlotinib; Ceritinib; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Cancer research; Cancer; Epidermal growth factor receptor; Adenocarcinoma; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001235964,0.0001249716,0.0002199165,0.0002436588,0.0002704098,0.0002814785,0.000160329,0.0003258624,0.01401406],"category_scores_gemma":[0.0004540817,0.00003682344,0.0003363974,0.0002232111,0.00008646286,0.0003071422,0.0002212336,0.0005231134,0.003110428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003573224,"about_ca_system_score_gemma":0.0004365984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009639256,"about_ca_topic_score_gemma":0.0047069,"domain_scores_codex":[0.9999231,0.00001578051,0.000006549089,0.0000093436,0.00002720524,0.00001799646],"domain_scores_gemma":[0.9998986,0.00001851906,0.00002215271,0.00000387676,0.00002033692,0.0000365465],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007269484,0.0002038242,0.01503605,0.0007656477,0.00007118597,0.001504813,0.00007979844,0.000226401,0.006252271,0.001477299,0.3595271,0.6141288],"study_design_scores_gemma":[0.0006755851,0.001292157,0.09023493,0.001210941,0.0001674413,0.007102883,0.0001158859,0.000939841,0.002956085,0.003562058,0.8917185,0.00002378096],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.1666836,0.2582258,0.005996111,0.09118898,0.00727168,0.0009016027,0.0094235,0.0009282898,0.4593804],"genre_scores_gemma":[0.7493172,0.1273734,0.005400477,0.03588507,0.006631166,0.0005691274,0.01021014,0.0001549427,0.06445846],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01401406,"threshold_uncertainty_score":0.04688174,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02476331531661414,"score_gpt":0.3389768553128095,"score_spread":0.3142135399961954,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}